Acetaminosalol

Acetaminosalol

SCHEMBL2521697

CC(=O)Nc1ccc(OC(=O)c2ccccc2O)cc1.[Mn]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.97
HSD17B10 Q99714 3/20 0.97
ALDH1A1 P00352 3/20 0.70
KDM4E B2RXH2 2/20 0.70
GLA P06280 1/20 0.70
ALOX15 P16050 1/20 0.61
KMT2A Q03164 8/20 0.58
MEN1 O00255 4/20 0.58
MAPT P10636 2/20 0.55
TSHR P16473 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.54
LMNA P02545 2/20 0.51
PNLIP P16233 3/20 0.51
NPSR1 Q6W5P4 1/20 0.51
NPC1 O15118 1/20 0.51
TP53 P04637 1/20 0.51
HTT P42858 1/20 0.51
RAB9A P51151 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetaminosalol SCHEMBL30383652 0.98 HPGD (1.00) HPGDHSD17B10ALDH1A1KDM4EGLA
Acetaminosalol SCHEMBL25220 0.98 HPGD (1.00) HPGDHSD17B10ALDH1A1KDM4EGLA
Acetaminosalol SCHEMBL8667882 0.97 HPGD (0.97) HPGDHSD17B10ALDH1A1KDM4EGLA
Acetaminosalol SCHEMBL579853 0.97 HPGD (0.97) HPGDHSD17B10ALDH1A1KDM4EGLA
Acetaminosalol SCHEMBL4777453 0.97 HPGD (0.97) HPGDHSD17B10ALDH1A1KDM4EGLA
Acetaminosalol SCHEMBL579851 0.97 HPGD (0.97) HPGDHSD17B10ALDH1A1KDM4EGLA
Acetaminosalol SCHEMBL18149032 0.97 HPGD (0.97) HPGDHSD17B10ALDH1A1KDM4EGLA
Acetaminosalol SCHEMBL4780360 0.97 HPGD (0.97) HPGDHSD17B10ALDH1A1KDM4EGLA
Acetaminosalol SCHEMBL27692402 0.97 HPGD (0.97) HPGDHSD17B10ALDH1A1KDM4EGLA
Acetaminosalol SCHEMBL3041383 0.97 HPGD (0.97) HPGDHSD17B10ALDH1A1KDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200190012-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2020-06-18 US claimed
US-10196341-B2 C-halogen bond formation THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2019-02-05 US claimed
US-20140227184-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2014-08-14 US claimed
EP-2744771-B1 C-HALOGEN BOND FORMATION UNIV PRINCETON (US) 2020-10-21 EP disclosed
US-20200190012-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2020-06-18 US disclosed
US-20190127311-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2019-05-02 US disclosed
US-10196341-B2 C-halogen bond formation THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2019-02-05 US disclosed
EP-2384325-B1 PROCESS FOR PREPARING DIVINYLARENE DIOXIDES BLUE CUBE IP LLC (US) 2018-04-04 EP disclosed
US-20160264512-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2016-09-15 US disclosed
CN-104529946-A Process for preparing divinylarene dioxides DOW GLOBAL TECHNOLOGIES LLC 2015-04-22 CN disclosed
WO-2015054476-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2015-04-16 WO disclosed
US-20140227184-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2014-08-14 US disclosed
EP-2744771-A1 C-HALOGEN BOND FORMATION The Trustees of Princeton University (US) 2014-06-25 EP disclosed
US-8497387-B2 Process for preparing divinylarene dioxides DOW GLOBAL TECHNOLOGIES LLC (US) 2013-07-30 US disclosed
WO-2013081685-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2013-06-06 WO disclosed
WO-2013028639-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2013-02-28 WO disclosed
CN-102272113-A Process for preparing divinylarene dioxides 2011-12-07 CN disclosed
EP-2384325-A1 PROCESS FOR PREPARING DIVINYLARENE DIOXIDES Dow Global Technologies LLC (US) 2011-11-09 EP disclosed
US-20110251412-A1 PROCESS FOR PREPARING DIVINYLARENE DIOXIDES BLUE CUBE IP LLC 2011-10-13 US disclosed
WO-2010077483-A1 PROCESS FOR PREPARING DIVINYLARENE DIOXIDES DOW GLOBAL TECHNOLOGIES INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190012-A1 C-HALOGEN BOND FORMATION CBR3, FOS, CBR1 HPGD 3589/4885HSD17B10 1746/4885ALDH1A1 3157/4885
US-20110251412-A1 PROCESS FOR PREPARING DIVINYLARENE DIOXIDES HAO2, DBN1, PPOX HPGD 90/4885HSD17B10 202/4885ALDH1A1 2572/4885
US-20140227184-A1 C-HALOGEN BOND FORMATION CBR3, FOS, CBR1 HPGD 3589/4885HSD17B10 1746/4885ALDH1A1 3157/4885
US-20160264512-A1 C-HALOGEN BOND FORMATION FOS, BCL3, CBR3 HPGD 4306/4885HSD17B10 2491/4885ALDH1A1 3937/4885
US-20190127311-A1 C-HALOGEN BOND FORMATION CBR3, FOS, CBR1 HPGD 3589/4885HSD17B10 1746/4885ALDH1A1 3157/4885
US-10196341-B2 C-halogen bond formation CBR3, FOS, CBR1 HPGD 3589/4885HSD17B10 1746/4885ALDH1A1 3157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.